Table 2.
Antibacterial activity of synthesized compounds against different microorganisms in the micro-broth dilution method. The antibacterial activity is expressed as the MIC/MBC (μg/mL).
| Microorganism | S. aureus | B. subtilis | E. coli | P. aeruginosa | C. albicans | C. glabrata |
|---|---|---|---|---|---|---|
| Ligand L | - | 31.25 | 31.25/31.25 | 31.25/- | 31.25/125 | - |
| Complex Co | - | 31.25/1000 | 31.25/31.25 | 31.25/250 | 62.5/- | - |
| Complex Ni | - | 31.25 | 31.25/31.25 | 31.25/2000 | - | - |
| Complex Cu | 31.25 | 31.25 | 31.25/31.25 | 31.25/500 | - | - |
| Complex Zn | - | 31.25 | 31.25/31.25 | 31.25/31.25 | - | - |
| Gentamicin * | 0.12/0.25 | 2/2 | 0.5/0.5 | 2/2 | - | - |
| Nystatin * | - | - | - | - | 1.25 | 0.625 |
Staphylococcus aureus (ATCC® 29213™), Bacillus subtilis (ATCC® 6633™), Escherichia coli (ATCC® 25922™), Pseudomonas aeruginosa (ATCC® 27853™), Candida albicans (ATCC® 10231™), and Candida glabrata (ATCC® 2001™). * Gentamicin and nystatin used as a standard control for bacteria and fungi, respectively.